| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |